BLOC1S6
protein-codingbiogenesis of lysosomal organelles complex 1 subunit 6, the group of Biogenesis of lysosomal organelles complex 1 subunits
Gene summary
The protein encoded by this gene may play a role in intracellular vesicle trafficking. It interacts with Syntaxin 13 which mediates intracellular membrane fusion. Mutations in this gene cause symptoms associated with Hermansky-Pudlak syndrome-9. Alternative splicing results in multiple transcript variants. A pseudogene related to this gene is located on the X chromosome. [provided by RefSeq, Aug 2015]
- PA
- PLDN
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~28.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013606
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013606
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013606
Submitter: ClinGen
*BLOC1S6* was first reported in relation to autosomal recessive Hermansky-Pudlak syndrome 9 in 2012 (Badolato et al., PMID: 22461475). Hermansky-Pudlak syndrome 9 is a subtype of HPS, characterized by oculocutaneous albinism and platelet dysfunction. *BLOC1S6* encodes the coiled-coil-forming protein, Pallidin, a subunit of the Biogenesis of Lysosome-related Organelles Complex 1, BLOC-1, which is required for normal biogenesis of specialized organelles of the endosomal-lysosomal system, such as melanosomes and platelet dense granules (PMID: 15102850). Of the 8 subunits of BLOC-1, mutations in three, including BLOC1S6, are reported in association with HPS subtypes in humans (Huizing et al., Hermansky-Pudlak Syndrome, GeneReviews). Evidence supporting this gene-disease relationship includes case-level and experimental data. Summary of Case Level Data (9 points): Six variants (nonsense, frameshift, and missense) in this gene have been reported in at least 5 probands in 5 publications (PMID: 22461475, 29054114, 26575419, 32245340, 33543539). The mechanism for disease is expected to be biallelic loss of function. Summary of Experimental Data (3 points): This gene-disease association is supported by studies of protein interaction with other subunits of BLOC-1 and by the spontaneously occurring mouse mutation, “pallid” that recapitulates the HPS phenotype. In summary, *BLOC1S6* is definitively associated with autosomal recessive Hermansky-Pudlak syndrome 9. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This gene-disease pair was originally evaluated by the HT GCEP on 09/23/2020. It was reevaluated on 05/25/2022. As a result of this reevaluation, the classification changed from Moderate to Definitive due to a new case report (PMID: 33543539).
Inheritance Pattern: AR
Disease ID:MONDO:0013606
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Ophthalmologic
Intervention: Allergy/Immunology/Infectious; Dermatologic; Hematologic; Ophthalmologic
Rationale: Prevention and treatment of bleeding episodes (eg, with DDAVP or platelet/RBC transfusions) can be effective, and aspirin-containing products should be avoided; Skin surveillance and protection can be beneficial; Surveillance related to ophthalmologic and other manifestations has been recommended in all individuals with HPS
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to BLOC1S6 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_012388.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 48 | 49 | |||
| missense | 1 | 64 | 4 | 69 | ||
| nonsense | 5 | 1 | 2 | 8 | ||
| start loss | 1 | 1 | 2 | |||
| frameshift | 10 | 3 | 4 | 17 | ||
| splice donor/acceptor (+/-2bp) | 2 | 7 | 9 | |||
| Total | 17 | 13 | 72 | 52 | 0 | 154 |
Highest pathogenic variant AF is 0.000013150628
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_036520.1 | 5 | MANE Select | |
| Ensembl | ENSP00000220531.4 | 5 | MANE Select | |
| RefSeq | NP_001298184.1 | 5 | Standard | |
| RefSeq | NP_001298185.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Golgi Associated Vesicle Biogenesis
- Clathrin derived vesicle budding
- trans-Golgi Network Vesicle Budding
- Vesicle-mediated transport
- Membrane Trafficking
Biological Process
- anterograde axonal transport
- synaptic vesicle docking
- neuron projection development
- melanosome transport
- melanosome organization
Molecular Function
- protein binding
- syntaxin binding
- identical protein binding
- protein homodimerization activity
- actin filament binding
Cellular Component
- cytoplasm
- cytosol
- extrinsic component of membrane
- transport vesicle
- BLOC-1 complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000220531
- Coding exons
- 5
- Length
- 28877
- Individuals with no LoFs
- 125715
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 27
- Defined
- 125742
- p
- 0.000107
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.859 | 64 | 86.5 | 0.740 | 0.00000386 | 1115 |
| Missense (PolyPhen) | 30 | 36.06 | 0.83195 | 512 | ||
| Synonymous | 0.132 | 32 | 33.0 | 0.971 | 0.00000146 | 307 |
| Loss of Function | -0.211 | 12 | 11.2 | 1.07 | 6.71e-7 | 130 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000026 | 0.000026 | rare |
| South Asian | 0.00029 | 0.00029 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. May play a role in intracellular vesicle trafficking, particularly in the vesicle-docking and fusion process. {ECO:0000269|PubMed:17182842, ECO:0000269|PubMed:21998198}.;
- Disease
- DISEASE: Hermansky-Pudlak syndrome 9 (HPS9) [MIM:614171]: A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS. {ECO:0000269|PubMed:21665000}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.232
Intolerance Scores
- RVIS EVS
- 0.13
- RVIS percentile EVS
- 62.74
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Low | Medium |
| Primary Immunodeficiency | Medium | Low | Medium |
| Cancer | Medium | Medium | Medium |